Screening

Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.

AI beats standard regression models at predicting lung cancer risk
Not all AI or regression models are the same, nor do they all incorporate the same data when assessing patient risk.
AI reduces CT lung cancer screening workload by nearly 80%
And it can do so with almost 100% accuracy as a first reader, according to a new large-scale analysis.
Abbreviated MRI protocols present suitable alternatives for liver cancer screening
Ultrasound is routinely used to screen for HCC. However, its utility is limited by numerous factors, including patient body habitus, operator experience and certain liver conditions, all of which contribute to decreases in sensitivity.
Routine abdominal CTs offer insight into cardiovascular risk
During this year's RSNA meeting, providers were especially interested in how AI applications could enhance opportunistic screening capabilities.
Screening efforts have helped avert millions of cancer-related deaths in recent decades
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.

AI beats standard regression models at predicting lung cancer risk

Not all AI or regression models are the same, nor do they all incorporate the same data when assessing patient risk.

AI reduces CT lung cancer screening workload by nearly 80%

And it can do so with almost 100% accuracy as a first reader, according to a new large-scale analysis.

Abbreviated MRI protocols present suitable alternatives for liver cancer screening

Ultrasound is routinely used to screen for HCC. However, its utility is limited by numerous factors, including patient body habitus, operator experience and certain liver conditions, all of which contribute to decreases in sensitivity.

Routine abdominal CTs offer insight into cardiovascular risk

During this year's RSNA meeting, providers were especially interested in how AI applications could enhance opportunistic screening capabilities.

Screening efforts have helped avert millions of cancer-related deaths in recent decades

In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.

Example of the four types of breast tissue density. The density of fibroglandular tissue inside the breast impacts the ability to easily see cancers. Cancers are very easy to spot in fatty breasts, but are almost impossible to find in extremely dense breasts. These examples show craniocaudal mammogram findings characterized as almost entirely fatty (far left), scattered areas of fibroglandular density (second from left), heterogeneously dense (second from right), and extremely dense (far right). RSNA

What breast density status can tell us about cardiovascular risk

Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.

HeartLung Technologies, a Houston-based artificial intelligence (AI) company, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new software that assesses chest CT scans for signs of coronary artery disease (CAD) and other potentially fatal heart conditions. The newly cleared offering, AutoChamber, was designed with opportunistic heart evaluations in mind.

FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.

Patients without PCPs struggle to access lung cancer screening, despite eligibility

It is estimated that up to one-third of the U.S. population does not have a primary care provider.

Around the web

Cardiovascular Business

ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH.

Radiology Business

Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business

‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.